Growing community of inventors

West Windsor, NJ, United States of America

Ming J Chen

Average Co-Inventor Count = 4.32

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 6

Ming J ChenHo-Wah Hui (4 patents)Ming J ChenThomas Lee (3 patents)Ming J ChenSekhar S Surapaneni (3 patents)Ming J ChenPaul Kurtulik (3 patents)Ming J ChenDora Visky (2 patents)Ming J ChenAnjali Agrawal (2 patents)Ming J ChenPrajwal Gunwanth Thool (2 patents)Ming J ChenRuimin Xie (2 patents)Ming J ChenShyam Babu Karki (2 patents)Ming J ChenAlexander L Ruchelman (1 patent)Ming J ChenJean-Marie Bernard (1 patent)Ming J ChenTerrence Joseph Connolly (1 patent)Ming J ChenXiaole Shen (1 patent)Ming J ChenJale Muslehiddinoglu (1 patent)Ming J ChenQiwen Han (1 patent)Ming J ChenMing J Chen (8 patents)Ho-Wah HuiHo-Wah Hui (24 patents)Thomas LeeThomas Lee (33 patents)Sekhar S SurapaneniSekhar S Surapaneni (9 patents)Paul KurtulikPaul Kurtulik (4 patents)Dora ViskyDora Visky (4 patents)Anjali AgrawalAnjali Agrawal (3 patents)Prajwal Gunwanth ThoolPrajwal Gunwanth Thool (3 patents)Ruimin XieRuimin Xie (2 patents)Shyam Babu KarkiShyam Babu Karki (2 patents)Alexander L RuchelmanAlexander L Ruchelman (56 patents)Jean-Marie BernardJean-Marie Bernard (47 patents)Terrence Joseph ConnollyTerrence Joseph Connolly (15 patents)Xiaole ShenXiaole Shen (1 patent)Jale MuslehiddinogluJale Muslehiddinoglu (1 patent)Qiwen HanQiwen Han (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Celgene Corporation (6 from 549 patents)

2. Rhodia Chimie (1 from 460 patents)

3. Signal Pharmaceuticals, Inc. (1 from 169 patents)


8 patents:

1. 12064427 - Pharmaceutical compositions comprising (S)-4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile and methods of using the same

2. 11779580 - Pharmaceutical compositions comprising (s)-4-(4-(4- (((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrtle and methods of using the

3. 9757355 - Oral dosage forms of cyclopropanecarboxylic acid {2-[(1S)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1H-isoindol-4-yl}-amide

4. 9616019 - Nanosuspension of a poorly soluble drug via microfluidization process

5. 9532977 - Controlled release oral dosage forms of poorly soluble drugs and uses thereof

6. 9434735 - Amorphous form of 4-((4-(cyclopentyloxy)-5-(2-methylbenzo[d]oxazol-6-yl)-7h-pyrrolo[2,3-d]pyrimidin-2-yl)amino)-3-methoxy-n-methylbenzamide, compositions thereof and methods of their use

7. 9023886 - Nanosuspension of a poorly soluble drug via microfluidization process

8. 6730405 - Polyisocyanate composition of low viscosity having a high functionality and preparation process

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/8/2025
Loading…